
WB analysis of various sample lysates using GTX54705 SUMO2 antibody. Dilution : 1:1000 Loading : 25microg per lane
SUMO2 antibody
GTX54705
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetSUMO2
Overview
- SupplierGeneTex
- Product NameSUMO2 antibody
- Delivery Days Customer7
- Application Supplier NoteWB: 1:500 - 1:2000. ICC/IF: 1:50 - 1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID6613
- Target nameSUMO2
- Target descriptionsmall ubiquitin like modifier 2
- Target synonymsHSMT3; sentrin 2; small ubiquitin-related modifier 2; SMT3 homolog 2; SMT3 suppressor of mif two 3 homolog 2; Smt3A; SMT3B; SMT3H2; SUMO3; ubiquitin-like protein SMT3A; ubiquitin-like protein SMT3B
- HostRabbit
- IsotypeIgG
- Protein IDP61956
- Protein NameSmall ubiquitin-related modifier 2
- Scientific DescriptionThis gene encodes a protein that is a member of the SUMO (small ubiquitin-like modifier) protein family. It functions in a manner similar to ubiquitin in that it is bound to target proteins as part of a post-translational modification system. However, unlike ubiquitin which targets proteins for degradation, this protein is involved in a variety of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. It is not active until the last two amino acids of the carboxy-terminus have been cleaved off. Numerous pseudogenes have been reported for this gene. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
- ReactivityHuman, Mouse, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Switch of NAD Salvage to de novo Biosynthesis Sustains SIRT1-RelB-Dependent Inflammatory Tolerance. Zhang J et al., 2019, Front ImmunolRead more